Products for Research Use Only
RegisterLogin

Vulinacimab

CAT: 0931-T76954Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0931-T76954Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
2250342-36-8
Target
VEGFR
Related Pathways
Tyrosine Kinase/Adaptors, Angiogenesis
Bioactivity
Vulinacimab (HLX-06), an anti-VEGFR-2 monoclonal antibody (mAb), plays a pivotal role in cancer research due to VEGFR-2's significant involvement in angiogenesis, as well as the proliferation, survival, migration, and differentiation of endothelial cells, processes critical for tumor growth where VEGFR-2 is overexpressed [1].
Shipping Conditions
Ice Packs
Storage Temperature
-20°C

Alternative Products

CatalogName
HY-P99516-01Vulinacimab
GTR18337816-01Vulinacimab Antibody
WA3806Research Grade Vulinacimab
E55B0469Vulinacimab (Reference antibody)
ICH5994-5mgVulinacimab Biosimilar - Research Grade
21-991Vulinacimab - Research Grade Biosimilar
GTR18697727-01Vulinacimab Human Monoclonal Antibody
GTR18780896-01(Vulinacimab) Biosimilar Reference Antibody
A3110-1mg*25Vulinacimab (Anti-VEGFR2 / KDR / CD309)
048150VEGFR2/KDR/CD309 (vulinacimab) discontinued

Popular Products